Forepont Capital Partners


Founded in 2017 in New York, Forepont Capital Partners is a global asset manager focused on healthcare and life sciences. The firm invests in biotech, medtech and e‑health start-ups in the United States and Europe and provides scientific, technological, financial and operational support. Forepont operates a medical research program and philanthropy funds for basic and academic research and leverages partnerships with physicians, researchers, academia, hospitals and pharmaceutical groups to source opportunities and support portfolio companies.

Industries

business-development
financial-services
funding-platform
venture-capital-b37d

Nr. of Employees

small (1-50)

Forepont Capital Partners

Forepont Capital LLC, 230 Park Avenue, 3rd Floor West, New York, NY 10169


Portfolio

Described as an innovative biotech company focused on the rapid diagnostics market.

#Biotech / Rapid diagnostics

Developing AI tools to prevent organ failure.

#Health AI / Organ failure prediction

Described as one of the pioneers of implantable neural interfaces.

#Braintech / Implantable neural interfaces

Described as a leader in implantable neural interface technology.

#Braintech / Neural interfaces

Described with the tagline 'Learn, innovate, act, transform.'

#Digital / Technology

Artificial intelligence applied to neurological diseases.

#Health AI / Neurology

View All Portfolio Items

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.